Retroviral gene therapy of collagen-induced arthritis by local delivery of IL-4

Clinical Immunology

Volumn 105, Issue 3, 2002, Pages 304-314

  Tarner, Ingo H ^a   Nakajima, Atsuo ^a   Seroogy, Christine M ^a   Ermann, Joerg ^a   Levicnik, Alenka ^a   Contag, Christopher H ^a   Fathman, C Garrison ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity; Bioluminescence imaging; Chemokines; Collagen induced arthritis; Cytokines; Gene therapy; IL 4; Retroviral vectors; Rheumatoid arthritis; T cell hybridomas; T cells; Targeted delivery

Indexed keywords

CHEMOKINE; COLLAGEN; CYTOKINE; INTERLEUKIN 4;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; BIOLUMINESCENCE; CELL TRANSFER; CHEMOTAXIS; CONTROLLED STUDY; GENE THERAPY; GENETIC TRANSDUCTION; HYBRIDOMA; IMMUNIZATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; RHEUMATOID ARTHRITIS; VIRUS GENE;

EID: 0036913264     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2002.5299     Document Type: Article

References (54)

1. Tarner, I. H., and Fathman, C. G. Gene therapy in autoimmune disease. Curr. Opin. Immunol. 13, 676, 2001.
2. Harris, E. D., Jr., Rheumatoid arthritis. Pathophysiology and implications for therapy. N. Engl. J. Med. 322, 1277, 1990.
3. Wollheim, F. A. Approaches to rheumatoid arthritis in 2000. Curr. Opin. Rheumatol. 13, 193, 2001.
4. Taylor, P. C., Anti-tumor necrosis factor therapies. Curr. Opin. Rheumatol. 13, 164, 2001.
5. Kamel, O. W., van de Rijn, M., Hanasono, M. M., and Warnke, R. A. Immunosuppression-associated lymphoproliferative disorders in rheumatic patients. Leukocyte Lymphoma 16, 363, 1995.
6. Beauparlant, P., Papp, K., and Haraoui, B. The incidence of cancer associated with the treatment of rheumatoid arthritis. Semin. Arthritis Rheum. 29, 148, 1999.
7. Panayi, G. S., Corrigall, V. M., and Pitzalis, C. Pathogenesis of rheumatoid arthritis. The role of T cells and other beasts. Rheum. Dis. Clin. North Am. 27, 317, 2001.
8. Holmdahl, R., Klareskog, L., Rubin, K., Larsson, E., and Wigzell, H. T lymphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen II-specific T-cell lines and clones. Scand. J. Immunol. 22, 295, 1985.
9. Ranges, G. E., Sriram, S., and Cooper, S. M. Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J. Exp. Med. 162, 1105, 1985.
10. Liblau, R. S., Singer, S. M., and McDevitt, H. O. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16, 34, 1995.
11. Mauri, C., Williams, R. O., Walmsley, M., and Feldmann, M. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur. J. Immunol. 26, 1511, 1996.
12. Mauritz, N. J., Holmdahl, R., Jonsson, R., Van der Meide, P. H., Scheynius, A., and Klareskog, L. Treatment with gamma-interferon triggers the onset of collagen arthritis in mice. Arthritis Rheum. 31, 1297, 1988.
13. Miossec, P., and van-den Berg, W., Th1/Th2 cytokine balance in arthritis. Arthritis Rheum. 40, 2105, 1997.
14. Begolka, W. S., Vanderlugt, C. L., Rahbe, S. M., and Miller, S. D., Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis. J. Immunol. 161, 4437, 1998.
15. Park, S. H., Min, D. J., Cho, M. L., Kim, W. U., Youn, J., Park, W., Cho, C. S., and Kim, H. Y., Shift toward T helper 1 cytokines by type II collagen-reactive T cells in patients with rheumatoid arthritis. Arthritis Rheum. 44, 561, 2001.
16. Feldmann, M., Brennan, F. M., and Maini, R. N., Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14, 397, 1996.
17. Annenkov, A., and Chernajovsky, Y., Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCR zeta. Gene Ther. 7, 714, 2000.
18. Costa, G. L., Benson, J. M., Seroogy, C. M., Achacoso, P., Fathman, C. G., and Nolan, G. P., Targeting rare populations of murine antigen-specific T lymphocytes by retroviral transduction for potential application in gene therapy for autoimmune disease. J. Immunol. 164, 3581, 2000.
19. Slavin, A., Tarner, I. H., Nakajima, A., Urbanek-Ruiz, I., McBride, J., Contag, C. H., and Fathman C. G., Adoptive cellular gene therapy of autoimmune disease. Autoimmuni. Revi. in press.
20. Shaw, M. K., Lorens, J. B., Dhawan, A., DalCanto, R., Tse, H. Y., Tran, A. B., Bonpane, C., Eswaran, S. L., Brocke, S., Sarvetnick, N., Steinman, L., Nolan, G. P., and Fathman C. G., Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J. Exp. Med. 185, 1711, 1997.
21. Nakajima, A., Seroogy, C. M., Sandora, M. R., Tarner, I. H., Costa, G. L., Taylor-Edwards, C., Bachmann, M. H., Contag, C. H., and Fathman, C. G., Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis. J. Clin. Invest. 107, 1293, 2001.
22. Costa, G. L., Sandora, M. R., Nakajima, A., Nguyen, E. V., Taylor-Edwards, C., Slavin, A. J., Contag, C. H., Fathman, C. G., and Benson, J. M., Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit. J. Immunol. 167, 2379, 2001.
23. Smith, R., Tarner, I. H., Hollenhorst, M., Lin, C., Levicnik, A. U., Fathman, C. G., and Nolan, G. P., Gene Therapy of Collagen-induced Arthritis by Retroviral Delivery of Anti-TNF scFv. manus. Submitted for publication.
24. Joosten, L. A., Lubberts, E., Durez, P., Helsen, M. M., Jacobs, M. J., Goldman, M., and van den Berg, W. B., Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum. 40, 249, 1997.
25. Cottard, V., Mulleman, D., Bouille, P., Mezzina, M., Boissier, M. C., and Bessis, N., Adeno-associated virus-mediated delivery of IL-4 prevents collagen-induced arthritis. Gene Ther. 7, 1930, 2000.
26. Kim, S. H., Evans, C. H., Kim, S., Oligino, T., Ghivizzani, S. C., and Robbins, P. D., Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4: Arthritis Res. 2, 293, 2000.
27. Joosten, L. A., Lubberts, E., Helsen, M. M., Saxne, T., Coenen-de Roo, C. J., Heinegard, D., and van den Berg, W. B., Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Arthritis Res. 1, 81, 1999.
28. van Roon, J. A., van Roy, J. L., Gmelig-Meyling, F. H., Lafeber, F. P., and Bijlsma, J. W., Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum. 39, 829, 1996.
29. Miossec, P., Chomarat, P., Dechanet, J., Moreau, J. F., Roux, J. P., Delmas, P., and Banchereau, J., Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis. Arthritis Rheum. 37, 1715, 1994.
30. Contag, C. H., Contag, P. R., Mullins, J. I., Spilman, S. D., Stevenson, D. K., and Benaron, D. A., Photonic detection of bacterial pathogens in living hosts. Mol. Microbiol. 18, 593, 1995.
31. Contag, P. R., Olomu, I. N., Stevenson, D. K., and Contag, C. H., Bioluminescent indicators in living mammals. Nature Med. 4, 245, 1998.
32. Edinger, M., Sweeney, T. J., Tucker, A. A., Olomu, A. B., Negrin, R. S., and Contag, C. H., Noninvasive assessment of tumor cell proliferation in animal models. Neoplasia 1, 303, 1999.
33. Sweeney, T. J., Mailander, V., Tucker, A. A., Olomu, A. B., Zhang, W., Cao, Y., Negrin, R. S., and Contag, C. H., Visualizing the kinetics of tumor-cell clearance in living animals. Proc. Natl. Acad. Sci. USA 96, 12044, 1999.
34. Luster, A. D., Chemokines - Chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338, 436, 1998.
35. Sallusto, F., Lanzavecchia, A., and Mackay, C. R., Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol. Today 19, 568, 1998.
36. D'Ambrosio, D., Iellem, A., Bonecchi, R., Mazzeo, D., Sozzani, S., Mantovani, A., and Sinigaglia, F., Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J. Immunol. 161, 5111, 1998.
37. Pear, W. S., Nolan, G. P., Scott, M. L., and Baltimore, D., Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90, 8392, 1993.
38. Yoshioka, T., Nakajima, A., Akiba, H., Ishiwata, T., Asano, G., Yoshino, S., Yagita, H., and Okumura, K., Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis. Eur. J. Immunol. 30, 2815, 2000.
39. von Andrian, U. H., and Mackay, C. R., T-cell function and migration. Two sides of the same coin. N. Engl. J. Med. 343, 1020, 2000.
40. Thornton, S., Duwel, L. E., Boivin, G. P., Ma, Y., and Hirsch, R., Association of the course of collagen-induced arthritis with distinct-patterns of cytokine and chemokine messenger RNA expression. Arthritis Rheum. 42, 1109, 1999.
41. Szekanecz, Z., Strieter, R. M., Kunkel, S. L., and Koch, A. E., Chemokines in rheumatoid arthritis. Springer Semin. Immunopathol. 20, 115, 1998.
42. Taylor, P. C., Peters, A. M., Paleolog, E., Chapman, P. T., Elliott, M. J., McCloskey, R., Feldmann, M., and Maini, R. N., Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis. Arthritis Rheum. 43, 38, 2000.
43. Buckley, C. D., Amft, N., Bradfield, P. F., Pilling, D., Ross, E., Arenzana-Seisdedos, F., Amara, A., Curnow, S. J., Lord, J. M., Scheel-Toellner, D., and Salmon, M., Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. J. Immunol. 165, 3423, 2000.
44. Nanki, T., Hayashida, K., El-Gabalawy, H. S., Suson, S., Shi, K., Girschick, H. J., Yavuz, S., and Lipsky, P. E., Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. J. Immunol. 165, 6590, 2000.
45. Matsui, T., Akahoshi, T., Namai, R., Watanabe, M., Nishimura, A., Endo, H., Kitasato, H., and Kondo, H., Selective recruitment of CCR-7 expressing cells by increased production of MIP-3beta in rheumatoid arthritis. Arthritis Rheum. 44, S46, 2001.
46. Matsui, T., Akahoshi, T., Namai, R., Hashimoto, A., Kurihara, Y., Rana, M., Nishimura, A., Endo, H., Kitasato, H., Kawai, S., Takagishi, K., and Kondo, H., Selective recruitment of CCR6-expressing cells by increased production of MIP-3 alpha in rheumatoid arthritis. Clin. Exp. Immunol. 125, 155, 2001.
47. Nakayama, Y., Matsui, T., Sato, H., Ogino, Y., Yamashita, C., Azuma, Y., Uno, H., Kamimura, T., Akahoshi, T., and Kondo, H., Regulated expression of MIP-3alpha and CCR6 in joint contribute to the pathogenesis of rheumatoid arthritis. Arthritis Rheum. 44, S47, 2001.
48. Kim, S. H., Kim, S., Evans, C. H., Ghivizzani, S. C., Oligino, T., and Robbins, P. D., Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4. J. Immunol. 166, 3499, 2001.
49. Morita, Y., Yang, J., Gupta, R., Shimizu, K., Shelden, E. A., Endres, J., Mule, J. J., McDonagh, K. T., and Fox, D. A., Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis. J. Clin. Invest. 107, 1275, 2001.
50. Lubberts, E., Joosten, L. A., Chabaud, M., van Den Bersselaar, L., Oppers, B., Coenen-De Roo, C. J., Richards, C. D., Miossec, P., and van Den Berg, W. B., IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion. J. Clin. Invest. 105, 1697, 2000.
51. Woods, J. M., Katschke, K. J., Volin, M. V., Ruth, J. H., Woodruff, D. C., Amin, M. A., Connors, M. A., Kurata, H., Arai, K., Haines, G. K., Kumar, P., and Koch, A. E., IL-4 adenoviral gene therapy reduces inflammation, proinflammatory cytokines, vascularization, and bony destruction in rat adjuvant-induced arthritis. J. Immunol. 166, 1214, 2001.
52. Ghivizzani, S. C., Lechman, E. R., Kang, R., Tio, C., Kolls, J., Evans, C. H., and Robbins, P. D., Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects. Proc. Natl. Acad. Sci. USA 95, 4613, 1998.
53. Lechman, E. R., Jaffurs, D., Ghivizzani, S. C., Gambotto, A., Kovesdi, I., Mi, Z., Evans, C. H., and Robbins, P. D., Direct adenoviral gene transfer of viral IL-10 to rabbit knees with experimental arthritis ameliorates disease in both injected and contralateral control knees. J. Immunol. 163, 2202, 1999.
54. Whalen, J. D., Lechman, E. L., Carlos, C. A., Weiss, K., Kovesdi, I., Glorioso, J. C., Robbins, P. D., and Evans, C. H., Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws. J. Immunol. 162, 3625, 1999.